Role of need assessment based family education of schizophrenic patients on recurrence of shizophrenia, patients performance and quality of life and family members, quality of life.

Comparative study of role of "current" and "need assessment based" family education of schizophrenic patients on recurrence of shizophrenia, patients performance and quality of life and family members, quality of life. A controlled study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201303172266N3

Enrollment

Registered

2013-05-15

Start date

2011-05-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

Intervention 1: Those in the control group will receive psycho-education based on the current protocols. Number of the sessions (10 sessions with 15 days intervals) and the structure were similar for

Treatment - Drugs

Those in the control group will receive psycho-education based on the current protocols. Number of the sessions (10 sessions with 15 days intervals) and the structure were similar for the two groups (

Those in the study group will receive psycho-education based on the current protocols. Number of the sessions (10 sessions with 15 days intervals) and the structure were similar for the two groups (At

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients with schizophrenia, diagnosed based on DSM-IV-TR Criteria and their families. Exclusion criteria: patients with debilitating diseases such as uncontrolled epilepsy and mental retardation and those who were addicted to any substance, drug, or alcohol were not included into the study. Also, those who had received psycho-education or family therapy during the past two years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study was improvement in symptoms severity. Timepoint: Every 3 months for 18 months. Method of measurement: Positive and Negative Syndrome Scale (PANSS).	—

Secondary

Measure	Time frame
Global function of the patients. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: Global assessment of function index(GAS0.;Patients’ quality of life. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: Schizophrenia Quality of Life Scale.;Quality of life of families. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: World Health Organization Quality of Life Questionnaire-Short Form.	—

Measure

Time frame

Global function of the patients. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: Global assessment of function index(GAS0.;Patients’ quality of life. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: Schizophrenia Quality of Life Scale.;Quality of life of families. Timepoint: Baseline and then every 6 months for 18 months. Method of measurement: World Health Organization Quality of Life Questionnaire-Short Form.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholam Reza Kheirabadi

Behavioral Sciences Research Center, Department of Psychiatry, school of medicine, Isfahan Universit

kheirabadi@bsrc.mui.ac.ir+98 31 1222 2135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026